Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 258)
Posted On: 11/07/2019 8:35:06 PM
Post# of 36568
Posted By: docj
Re: docj #8158
From the Jan 2019 news about the GNBT purchase of Olaregen(Excellagen)

"Excellagen has a reimbursement code by the Healthcare Common Procedure Coding System that has a unique Q Code designation 4149 referred to as a skin substitute."

I looked up the code in the Medicare fee schedule and there is no value assigned. Not surprising as "skin substitute" is very generic. Just curious if Olaregen has begun the process of seeing if Medicare is going to cover the product and if so, how much will they reimburse. Are they going to be assigned a more specific HCPCS code for the product?

This code was assigned back 2014.

2019 HCPCS Code Q4149
Excellagen, 0.1 cc

Report Advertisement
Short Description
Excellagen, 0.1 cc
HCPCS Coverage Code
C = Carrier judgment
HCPCS Action Code
N = No maintenance for this code
HCPCS Action Effective Date
January 01, 2014
HCPCS Code Added Date
January 01, 2014
HCPCS Pricing Indicator Code
51 = Drugs
HCPCS Multiple Pricing Indicator Code
A = Not applicable as HCPCS priced under one methodology
HCPCS Type Of Service Code
1 = Medical care
HCPCS Anesthesia Base Unit Quantity
0













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site